Picture2.jpg

Applying Synthetic Biology To Orphan Drug Development


2020 Harvard President's Challenge Finalist (LifeScience Track)

 
Test Tubes

Detection, Visualization & Orphan Drug Development

Our product candidates are designed to improve detection, visualization and treatment of rare diseases of The Alimentary Track. We plan to file IND's With the US FDA and Other Appropriate Regulatory Authorities to Support Their Clinical Development.

SB-101 Is Designed to Significantly Improve Colonoscopy Outcomes for Lynch Syndrome Patients 

SB-201 Is a Potential New Therapeutic Paradigm for The Treatment of Familial Adenomatous Polyposis

 

"Big results require big ambitions"

Heraclitus

Petri Dish
 

Want To Learn More?

BloodCells.jpg
 

Address

Pagliuca Harvard Life Lab

127 Western Ave

Allston MA 02139

USA

Contact

6174478299

©2019 by FEP Capital Advisors, LLC.